Beleaguered World Health Organization Wades Into Transgender Debate and Is Met With Uproar Over Plans To Develop Guidelines on Trans Healthcare
February 1, 2024
In the media
On Thursday, the Society for Evidence Based Gender Medicine, or SEGM, issued its second letter criticizing the WHO’s effort, critiquing the guidelines-development process as apparently flawed from the time of its quiet inception two to three years ago.
SEGM, in its new letter, asserted that those original two WHO guidelines made claims, specifically that cross-sex hormone access by trans persons is universally beneficial and that legal recognition of persons’ self-declared gender is a human right, that were “poorly-evidenced.” SEGM criticized the organization for apparently treating those two fundamental questions as settled facts by simple virtue of their inclusion in such previous guidance and expressed an “overarching concern that the WHO may be inadvertently involved in the production of a biased guideline.”